SecSonar.com

Globus Medical, Inc. (GMED)

Globus Medical, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Globus Medical, Inc. (GMED) is a Medical - Devices company based in US with a market capitalization of $11.1B. Revenue grew 16.6% year-over-year and the company generated $588.8M in free cash flow. This page tracks GMED's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 5.3K employees · IPO Aug 3, 2012

Valuation

Valuation & price

$76.64 · as of May 17, 2026 · -20.8% vs 52w high

19.6

P/E ratio

Latest-FY diluted EPS

2.42

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$96.71$74.30$51.89Jul 25Dec 25Jul 26Jul 7, 25$55.97Jul 9, 25$57.31Jul 11, 25$57.12Jul 15, 25$55.87Jul 17, 25$57.55Jul 21, 25$51.89Jul 23, 25$54.04Jul 25, 25$54.48Jul 29, 25$54.04Jul 31, 25$52.63Aug 4, 25$53.63Aug 6, 25$52.83Aug 11, 25$59.43Aug 13, 25$62.79Aug 15, 25$60.57Aug 19, 25$61.17Aug 21, 25$60.50Aug 25, 25$61.38Aug 27, 25$61.51Aug 29, 25$61.27Sep 3, 25$58.80Sep 5, 25$60.60Sep 9, 25$59.08Sep 11, 25$59.62Sep 16, 25$57.84Sep 18, 25$56.75Sep 22, 25$56.81Sep 24, 25$55.30Sep 26, 25$55.70Sep 30, 25$57.27Oct 2, 25$58.06Oct 6, 25$60.17Oct 8, 25$60.42Oct 10, 25$56.57Oct 14, 25$58.09Oct 16, 25$58.57Oct 21, 25$62.73Oct 23, 25$62.80Oct 27, 25$63.26Oct 29, 25$61.48Oct 31, 25$60.39Nov 4, 25$61.66Nov 6, 25$61.71Nov 10, 25$86.36Nov 12, 25$84.71Nov 14, 25$84.45Nov 18, 25$83.42Nov 20, 25$82.28Nov 25, 25$91.18Nov 28, 25$91.04Dec 2, 25$89.03Dec 4, 25$88.74Dec 8, 25$89.00Dec 10, 25$87.82Dec 12, 25$86.70Dec 16, 25$85.79Dec 18, 25$86.88Dec 22, 25$89.36Dec 24, 25$88.43Dec 29, 25$88.36Jan 2, 26$87.30Jan 6, 26$93.29Jan 8, 26$94.62Jan 12, 26$91.72Jan 14, 26$92.46Jan 16, 26$93.47Jan 21, 26$94.15Jan 23, 26$92.52Jan 27, 26$91.96Jan 29, 26$90.22Feb 2, 26$89.70Feb 4, 26$87.06Feb 9, 26$87.59Feb 11, 26$88.26Feb 13, 26$88.09Feb 18, 26$90.15Feb 20, 26$90.59Feb 24, 26$91.88Feb 26, 26$96.71Mar 2, 26$93.80Mar 4, 26$90.46Mar 6, 26$87.10Mar 10, 26$86.65Mar 12, 26$84.51Mar 17, 26$88.16Mar 19, 26$86.30Mar 23, 26$87.21Mar 25, 26$87.35Mar 27, 26$83.78Mar 31, 26$86.16Apr 2, 26$87.92Apr 7, 26$90.00Apr 9, 26$91.40Apr 13, 26$92.98Apr 15, 26$94.55Apr 17, 26$95.25Apr 22, 26$95.00Apr 24, 26$94.87Apr 28, 26$90.74Apr 30, 26$90.18May 4, 26$90.60May 6, 26$89.22May 8, 26$77.95May 12, 26$76.13May 14, 26$77.21May 18, 26$78.93May 20, 26$84.03May 22, 26$84.81May 28, 26$82.45Jun 1, 26$79.78Jun 3, 26$77.95Jun 5, 26$80.00Jun 9, 26$82.52Jun 11, 26$80.52Jun 15, 26$77.32Jun 17, 26$75.42Jun 22, 26$79.19Jun 24, 26$82.12Jun 26, 26$86.25Jul 2, 26$80.12
$51.8952-week range$96.82
Loading valuation history…

Fundamentals

Key fundamentals

$11.1B

Market cap

16.6%

Revenue growth (YoY)

67.4%

Gross margin

$588.8M

Free cash flow (USD)

-$438.6M

Net debt

Net cash position

-0.4%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$564.0MFY 2017$636.0MFY 2018$713.0MFY 2019$785.4MFY 2020$789.0MFY 2021$958.1MFY 2022$1.0BFY 2023$1.6BFY 2024$2.5BFY 2025$2.9B
$564M$2.9B

Free cash flow by year

2016 → 2025

FY 2016$131.0MFY 2017$108.2MFY 2018$121.9MFY 2019$101.2MFY 2020$135.1MFY 2021$219.4MFY 2022$104.4MFY 2023$165.2MFY 2024$405.2MFY 2025$588.8M
$131M$588.8M

Gross margin by year

2021 → 2025

FY 202175.0%FY 202274.2%FY 202365.0%FY 202458.9%FY 202567.4%
75.0%67.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan UpdateJun 4, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Globus Medical, Inc.'s market cap?

Globus Medical, Inc. (GMED) has a market capitalization of $11.1B.

What is GMED's P/E ratio?

GMED trades at a price-to-earnings ratio of 19.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is GMED's price-to-book (P/B) ratio?

GMED trades at 2.42 times book value per share.

Are insiders buying GMED stock?

SEC Form 4 filings show no open-market insider buys at Globus Medical, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

PODD

Insulet Corporation

$9.9B

PEN

Penumbra, Inc.

$12.5B

ALGN

Align Technology, Inc.

$12.6B

SNN

Smith & Nephew plc

$12.7B

MASI

Masimo Corporation

$9.3B

BRKR

Bruker Corporation

$8.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.